VEGF-targeted scFv inhibits corneal neovascularization via STAT3 pathway in alkali burn model
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VEGF-targeted scFv inhibits corneal neovascularization via STAT3 pathway in alkali burn model
Authors
Keywords
-
Journal
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
Volume 658, Issue -, Pages 130764
Publisher
Elsevier BV
Online
2022-12-10
DOI
10.1016/j.colsurfa.2022.130764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv
- (2022) Merve Arslan et al. Scientific Reports
- One-step synthesis of a radioiodinated anti-microRNA-21 oligonucleotide for theranostics in prostate tumor xenografts
- (2022) Shaozhong Xian et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy
- (2022) Paola Muñoz-López et al. Cancers
- Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer
- (2021) Chunfeng Xie et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation
- (2021) Yu Ma et al. DRUG DELIVERY
- 64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma
- (2021) Lei Kang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Expression of Single Chain Variable Fragment (scFv) Molecules in Plants: A Comprehensive Update
- (2020) Padikara Kutty Satheeshkumar MOLECULAR BIOTECHNOLOGY
- Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration
- (2020) Quan Dong Nguyen et al. OPHTHALMOLOGY
- DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma
- (2020) Anthony B. Eason et al. PLoS One
- Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
- (2020) Zachary Barry et al. MOLECULES
- Noninvasive evaluation of CD20 expression using 64Cu-labeled F(ab')2 fragments of obinutuzumab in lymphoma
- (2020) Lei Kang et al. JOURNAL OF NUCLEAR MEDICINE
- Self-Assembly of amphiphilic BODIPY derivative and its nanoparticles as a photosensitizer for photodynamic therapy in corneal neovascularization
- (2019) Wenmin Jiang et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Optical Coherence Tomography Angiography Imaging to monitor Anti-VEGF treatment of Corneal Vascularization in a Rabbit Model
- (2019) Kavya Devarajan et al. Scientific Reports
- ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab
- (2018) Lei Kang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Antitumor Activity of DLX1008, an Anti-VEGFA Antibody Fragment with Low Picomolar Affinity, in Human Glioma Models
- (2018) Emese Szabó et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Current and emerging therapies for corneal neovascularization
- (2018) Danial Roshandel et al. Ocular Surface
- Inhibited Corneal Neovascularization in Rabbits following Corneal Alkali Burn by Double-Target Interference for VEGF and HIF-1α
- (2018) Ying-Cong Fu et al. BIOSCIENCE REPORTS
- AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization
- (2018) Chris P. Hughes et al. Molecular Therapy-Methods & Clinical Development
- Animal models of ocular angiogenesis: from development to pathologies
- (2017) Chi-Hsiu Liu et al. FASEB JOURNAL
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- Native SDS-PAGE: high resolution electrophoretic separation of proteins with retention of native properties including bound metal ions
- (2014) Andrew B. Nowakowski et al. Metallomics
- Topical Ranibizumab as a Treatment of Corneal Neovascularization
- (2013) Giulio Ferrari et al. CORNEA
- Intrastromal injection of bevacizumab in patients with corneal neovascularization
- (2012) Ana Carolina Cabreira Vieira et al. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
- Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial
- (2012) Constantinos Petsoglou et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- scFv Antibody: Principles and Clinical Application
- (2012) Zuhaida Asra Ahmad et al. Clinical & Developmental Immunology
- Intravitreous bevacizumab adult safety data: the evidence so far
- (2012) Salmaan Al-Qureshi et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Anti-VEGF Treatment of Corneal Neovascularization
- (2012) Anne M. Keating et al. Ocular Surface
- Corneal Neovascularization: An Anti-VEGF Therapy Review
- (2012) Jin-Hong Chang et al. SURVEY OF OPHTHALMOLOGY
- Inhibition of Corneal Neovascularization by Topical Bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an Animal Model
- (2010) Juan J. Pérez-Santonja et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Effect of Subconjunctival and Intraocular Bevacizumab Injections on Corneal Neovascularization in a Mouse Model
- (2010) Inbal Avisar et al. CURRENT EYE RESEARCH
- Topical Bevacizumab in the Treatment of Corneal Neovascularization
- (2009) Mohammad H. Dastjerdi ARCHIVES OF OPHTHALMOLOGY
- Development trends for therapeutic antibody fragments
- (2009) Aaron L Nelson et al. NATURE BIOTECHNOLOGY
- Role of Stat3 in suppressing anti-tumor immunity
- (2008) Marcin Kortylewski et al. CURRENT OPINION IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now